Citation Impact
Citing Papers
Parenteral Anticoagulants
2012 Standout
Electrospinning of Polymeric Nanofibers for Tissue Engineering Applications: A Review
2006 Standout
Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate
2002
A six‐month randomized, controlled, double‐blind, dose‐response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug–refractory ankylosing spondylitis
2002
Osteonecrosis of the Jaw in a Patient on Denosumab
2010
Evaluation of Two Putative Susceptibility Loci for Oral Clefts in the Danish Population
2001
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism
1989
Chronic Venous Disease
2006 Standout
Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone Resorption
2003
Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications
1994 Standout
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
2004 Standout
Preparation and Characterization of Novel Poly(methylidene Malonate 2.1.2.)-Made Nanoparticles
1994
Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation
2000
Comparison of Microcomputed Tomographic and Microradiographic Measurements of Cortical Bone Porosity
2004
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
1993 Standout
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications
2003
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
SEM and TEM study of the hierarchical structure of C57BL/6J and C3H/HeJ mice trabecular bone
2004
Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three‐year randomized, double‐blind trial
1996
The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats
2004
FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease
2002 Standout
Skeletal remodeling in health and disease
2007 Standout
Systematic review of the chemical composition of contemporary dental adhesives
2007 Standout
Porosity of 3D biomaterial scaffolds and osteogenesis
2005 Standout
Tumor necrosis factor α‐mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin
2002
Cleft lip and palate
2009 Standout
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
Biodegradable polymeric nanoparticles as drug delivery devices
2001 Standout
Ankylosing spondylitis
2007 Standout
The Temporal Changes of Trabecular Architecture in Ovariectomized Rats Assessed by MicroCT
2001
Root Canal Irrigants
2006 Standout
How were new medicines discovered?
2011 Standout
Overview of bisphosphonates
1997
Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis
1999
New developments in polymer-controlled, bioinspired calcium phosphate mineralization from aqueous solution
2013
Micro- and nano-structural analyses of damage in bone
2005
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Excised Bone Structures in Mice: Imaging at Three-dimensional Synchrotron Radiation Micro CT
2003
Novel crosslinking methods to design hydrogels
2002 Standout
Bisphosphonates: The first 40years
2011
Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat
2007
[20] Role of 1α,25-dihydroxyvitamin D3 in osteoclast differentiation and function
1997
Non-peptide arginine-vasopressin antagonists: the vaptans
2008
Surface treatments of titanium dental implants for rapid osseointegration
2006 Standout
Electrospinning: A fascinating fiber fabrication technique
2010 Standout
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Bisphosphonates: mechanisms of action.
1996
Biodegradable Polymers for Protein and Peptide Drug Delivery
1995
Effect of pumpkin-seed oil on the level of free radical scavengers induced during adjuvant-arthritis in rats
1995
Biodegradability of poly (2-hydroxyethyl methacrylate) in the presence of the J774.2 macrophage cell line
2004
Effects of low-dose long-term sodium fluoride preventive treatment on rat bone mass and biomechanical properties
1996
Mechanical consequence of trabecular bone loss and its treatment: a three-dimensional model simulation
2002
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Bisphosphonates: from the laboratory to the clinic and back again
1999
Protein release from gelatin matrices
1998
Effect of Bisphosphonate (Incadronate) on Fracture Healing of Long Bones in Rats
1999
Evaluation of Therapeutic Compression Stockings in the Treatment of Chronic Venous Insufficiency
1999
Oil and Tocopherol Content and Composition of Pumpkin Seed Oil in 12 Cultivars
2007 Standout
Age-Related Changes in Trabecular Architecture Differ in Female and Male C57BL/6J Mice
2007
The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum
2011 Standout
Synchrotron Radiation Microtomography Allows the Analysis of Three-Dimensional Microarchitecture and Degree of Mineralization of Human Iliac Crest Biopsy Specimens: Effects of Etidronate Treatment
2002
Bone Resorption by Osteoclasts
2000 StandoutScience
Interparticle Coupling Effect on the Surface Plasmon Resonance of Gold Nanoparticles: From Theory to Applications
2007 Standout
Osteoclastogenesis, Bone Resorption, and Osteoclast-Based Therapeutics
2003
Hydrogels for Tissue Engineering
2001 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Changes in Bone Structure and Mass With Advancing Age in the Male C57BL/6J Mouse
2002
Small Particles in Medicine
1995
Cyclodextrin Drug Carrier Systems
1998 Standout
Preparation of Porous Polysaccharides Templated by Coordination Polymer with Three-Dimensional Nanochannels
2017 StandoutNobel
Biodegradable polymers as biomaterials
2007 Standout
Regulation of Osteoclast Function
1997
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption
1998
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
2013
The Chemistry and Biochemistry of Vanadium and the Biological Activities Exerted by Vanadium Compounds
2004 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Venous Hypertension, Inflammation and Valve Remodeling
2004
PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
1998
Noninvasive In Vivo Monitoring of Bone Architecture Alterations in Hindlimb-Unloaded Female Rats Using Novel Three-Dimensional Microcomputed Tomography
2003
Comparison Insight Bone Measurements by Histomorphometry and μCT
2005
Controlled release of the LHRH agonist buserelin acetate from injectable suspensions containing triacetylated cyclodextrins in an oil vehicle
1994
A Histomorphometric Comparison of the Effects of Heparin and Low-Molecular-Weight Heparin on Cancellous Bone in Rats
1997
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Guidelines for assessment of bone microstructure in rodents using micro–computed tomography
2010 Standout
Nature’s hierarchical materials
2007 Standout
Microglial M1/M2 polarization and metabolic states
2015 Standout
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
1999 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Nano- and microparticles for the delivery of polypeptides and proteins
1993
Long-Term Treatment of Incadronate Disodium Accumulates Microdamage but Improves the Trabecular Bone Microarchitecture in Dog Vertebra
2003
Vascular Calcification
2008 Standout
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Micellization of block copolymers
2003 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Bisphosphonates: Mechanisms of Action
1998
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
1999
Calcium phosphates in biomedical applications: materials for the future?
2015 Standout
Micro-CT in small animal and specimen imaging
2002
Works of A. Barbier being referenced
Effect of SR121463, a Selective Non-Peptide Vasopressin V 2 Receptor Antagonist, in a Rabbit Model of Ocular Hypertension
2000
Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts
1997
SSR126768A (4-Chloro-3-[(3 R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2- oxo-2,3-dihydro-1 H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, Hydrochloride): A New Selective and Orally Active Oxytocin Receptor Antagonist for the Prevention of Preterm Labor
2004
High-Resolution Three-Dimensional Micro-Computed Tomography Detects Bone Loss and Changes in Trabecular Architecture Early
2002
Ultrastructural Properties of Bone Mineral of Control and Tiludronate-Treated Osteoporotic Rat
2000
Characterization of the trabecular rat bone mineral: effect of ovariectomy and bisphosphonate treatment
2000
Poly(2-hydroxy ethyl methacrylate)-alkaline phosphatase: A composite biomaterial allowing in vitro studies of bisphosphonates on the mineralization process
2000
The visualization and evaluation of bone architecture in the rat using three-dimensional X-Ray microcomputed tomography
1999
Bisphosphonate tiludronate increases bone strength by improving mass and structure in established osteopenia after ovariectomy in rats
1997
A possible mechanism of the specific action of bisphosphonates on osteoclasts: Tiludronate preferentially affects polarized osteoclasts having ruffled borders
1995
Studies on the chronic phase of adjuvant arthritis: effect of SR 41319, a new diphosphonate.
1986
Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy
1994
Comparative study of etidronate and SR 41319, a new diphosphonate, on passive cutaneous anaphylaxis and phospholipase A2 activity
1985
Bisphosphonate Effects in Rat Unloaded Hindlimb Bone Loss Model: Three-Dimensional Microcomputed Tomographic, Histomorphometric, and Densitometric Analyses
1999
The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H+-ATPase
1996
[Microcirculation and rheology].
1994
[Venous hemodynamics of the lower limbs].
1994
Longitudinal effect of tiludronate on bone mineral density, resonant frequency, and strength in monkeys
1992
Biochemical and clinical changes in rats with developing adjuvant arthritis
1984
Biodegradable nanoparticles for subcutaneous administration of growth hormone releasing factor (hGRF)
1992